Page last updated: 2024-08-17

lactose and fluticasone

lactose has been researched along with fluticasone in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (24.00)29.6817
2010's17 (68.00)24.3611
2020's2 (8.00)2.80

Authors

AuthorsStudies
Bye, A; Daley-Yates, PT; Falcoz, C; McDowall, JE; Oliver, R; Ventresca, P1
Hickey, AJ; Louey, MD; Van Oort, M1
Dawson, ML; Ferrie, AR; Harris, H; Hooton, JC; Jones, MD; King, GS; Mathoulin, CA; Nichol, K; Price, R; Shur, J; Smith, TL1
Marriott, C; Martin, GP; Murnane, D1
Donovan, R; Elder, D; Freney, E; New, A; Prime, D; Zomer, S1
Fujita, K; Ise, Y; Ishii-Nozawa, R; Katayama, S; Takeuchi, K1
Hickey, AJ; Langridge, J; Mansour, HM; McLean, R; Mulder, T; Xu, Z1
Flament, MP; Le, VN; Robins, E2
Marriott, C; Martin, GP; Taki, M; Zeng, XM1
Bierend, H; Flament, MP; Le, VN; Robins, E; Steckel, H1
Flament, MP; Hoang Thi, TH; Le, VN; Robins, E2
de Boer, HA; Frijlink, HW; Grasmeijer, F; Hagedoorn, P1
Collins, E; Forbes, B; Hammond, RB; Jaffari, S; Martin, GP; Murnane, D; Pencheva, K; Pickering, J; Ramachandran, V; Roberts, KJ; Soufian, M1
Depasquale, R; Lee, SL; Price, R; Saluja, B; Shur, J1
Abdul, S; Darshana, H; Gaikwad, RV; Jain, RR; Menon, MD; Singh, DJ; Soni, PS1
Lee, S; Price, R; Saluja, B; Shur, J; Tibbatts, J1
Hoe, S; Lechuga-Ballesteros, D; Vehring, R; Wang, H; Williams, L1
Elsayed, MM; Molokhia, AM; Shalash, AO1
Elsayed, MMA; Shalash, AO1
Choi, HG; Jin, SG; Kim, DW; Kim, JH; Kim, JO; Kim, KS; Oh, KT; Woo, JS; Yong, CS; Youn, YS1
Elsayed, MMA; Khalafallah, NM; Molokhia, AM; Shalash, AO1
Chan, HK; Holl, MMB; Ke, WR; Khanal, D; Kim, J; Zhang, J1
Guan, J; He, X; Li, J; Ma, S; Mao, S; Sun, Y; Zhang, X1

Trials

1 trial(s) available for lactose and fluticasone

ArticleYear
Bioavailability of orally administered micronised fluticasone propionate.
    Clinical pharmacokinetics, 2000, Volume: 39 Suppl 1

    Topics: Administration, Oral; Adult; Androstadienes; Anti-Asthmatic Agents; Biological Availability; Capsules; Cross-Over Studies; Double-Blind Method; Fluticasone; Humans; Hydrocortisone; Lactose; Male

2000

Other Studies

24 other study(ies) available for lactose and fluticasone

ArticleYear
Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations.
    Pharmaceutical research, 2004, Volume: 21, Issue:7

    Topics: Administration, Inhalation; Aerosols; Androstadienes; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Excipients; Fluticasone; Lactose; Microscopy, Electron, Scanning; Particle Size; Powders; Temperature

2004
An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2008, Volume: 69, Issue:2

    Topics: Adhesiveness; Administration, Inhalation; Albuterol; Androstadienes; Anti-Allergic Agents; Capsules; Chemistry, Pharmaceutical; Crystallization; Drug Carriers; Excipients; Fluticasone; Lactose; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Particle Size; Powders; Salmeterol Xinafoate; X-Ray Diffraction

2008
Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals.
    Journal of pharmaceutical sciences, 2009, Volume: 98, Issue:2

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aerosols; Albuterol; Androstadienes; Bronchodilator Agents; Chemistry, Pharmaceutical; Crystallization; Drug Compounding; Fluticasone; Lactose; Nebulizers and Vaporizers; Particle Size; Polyethylene Glycols; Powders; Salmeterol Xinafoate

2009
Detection and assessment of co-association in inhalable drug particles using aerosol time-of-flight mass spectrometry.
    Rapid communications in mass spectrometry : RCM, 2008, Volume: 22, Issue:23

    Topics: Administration, Inhalation; Aerosols; Albuterol; Androstadienes; Bronchodilator Agents; Drug Combinations; Fluticasone; Fluticasone-Salmeterol Drug Combination; Humans; Lactose; Mass Spectrometry; Metered Dose Inhalers; Multivariate Analysis; Nebulizers and Vaporizers; Particle Size; Principal Component Analysis; Salmeterol Xinafoate

2008
[Survey of the drugs remaining in the diskhaler and investigation of cleaning of fluticasone propionate].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2009, Volume: 129, Issue:3

    Topics: Adhesiveness; Administration, Inhalation; Adult; Aged; Aged, 80 and over; Androstadienes; Female; Fluticasone; Humans; Lactose; Male; Metered Dose Inhalers; Middle Aged; Surveys and Questionnaires; Young Adult

2009
Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 2. Ipratropium bromide monohydrate and fluticasone propionate.
    Journal of pharmaceutical sciences, 2010, Volume: 99, Issue:8

    Topics: Administration, Inhalation; Aerosols; Algorithms; Androstadienes; Bronchodilator Agents; Calorimetry, Differential Scanning; Drug Carriers; Drug Compounding; Fluticasone; Ipratropium; Lactose; Lasers; Microscopy, Electron, Scanning; Particle Size; Powders; X-Ray Diffraction

2010
Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2010, Volume: 76, Issue:3

    Topics: Administration, Inhalation; Air; Androstadienes; Bronchodilator Agents; Drug Delivery Systems; Dry Powder Inhalers; Excipients; Fluticasone; Lactose; Models, Theoretical; Particle Size; Permeability; Powders; Terbutaline

2010
The production of 'aerodynamically equivalent' drug and excipient inhalable powders using a novel fractionation technique.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2011, Volume: 77, Issue:2

    Topics: Administration, Inhalation; Aerosols; Albuterol; Androstadienes; Anti-Allergic Agents; Bronchodilator Agents; Chemical Fractionation; Crystallization; Drug Compounding; Excipients; Fluticasone; Humans; Lactose; Nebulizers and Vaporizers; Particle Size; Powders; Salmeterol Xinafoate

2011
Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate.
    International journal of pharmaceutics, 2012, Jan-17, Volume: 422, Issue:1-2

    Topics: Adhesiveness; Adsorption; Aerosols; Androstadienes; Bronchodilator Agents; Chemistry, Pharmaceutical; Chromatography, Gas; Drug Carriers; Drug Compounding; Fluticasone; Lactose; Particle Size; Powders; Technology, Pharmaceutical; Terbutaline

2012
Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2012, Volume: 80, Issue:3

    Topics: Administration, Inhalation; Aerosols; Androstadienes; Chemistry, Pharmaceutical; Drug Carriers; Dry Powder Inhalers; Fluticasone; Lactose; Particle Size; Powders; Silica Gel

2012
In vitro evaluation of powders for inhalation: the effect of drug concentration on particle detachment.
    International journal of pharmaceutics, 2012, Mar-15, Volume: 424, Issue:1-2

    Topics: Adhesiveness; Androstadienes; Bronchodilator Agents; Chemistry, Pharmaceutical; Drug Carriers; Dry Powder Inhalers; Ethanolamines; Fluticasone; Formoterol Fumarate; Lactose; Powders

2012
Dry powder inhalers: study of the parameters influencing adhesion and dispersion of fluticasone propionate.
    AAPS PharmSciTech, 2012, Volume: 13, Issue:2

    Topics: Adhesiveness; Administration, Inhalation; Aerosols; Androstadienes; Bronchodilator Agents; Chemistry, Pharmaceutical; Drug Carriers; Drug Storage; Dry Powder Inhalers; Fluticasone; Humidity; Lactose; Particle Size; Powders; Technology, Pharmaceutical; Time Factors; Water

2012
Mixing time effects on the dispersion performance of adhesive mixtures for inhalation.
    PloS one, 2013, Volume: 8, Issue:7

    Topics: Administration, Inhalation; Albuterol; Androstadienes; Chemistry, Pharmaceutical; Drug Carriers; Fluticasone; Lactose; Lasers; Microscopy, Electron, Scanning; Particle Size; Salmeterol Xinafoate; Solubility; Time Factors; X-Ray Diffraction

2013
Formulation pre-screening of inhalation powders using computational atom-atom systematic search method.
    Molecular pharmaceutics, 2015, Jan-05, Volume: 12, Issue:1

    Topics: Administration, Inhalation; Aerosols; Albuterol; Androstadienes; Budesonide; Chemistry, Pharmaceutical; Chromatography, Gas; Computer Simulation; Crystallization; Drug Delivery Systems; Excipients; Fluticasone; Hydrogen Bonding; Lactose; Lasers; Models, Theoretical; Particle Size; Powders; Static Electricity; Surface Properties

2015
The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate.
    AAPS PharmSciTech, 2015, Volume: 16, Issue:3

    Topics: Administration, Inhalation; Bronchodilator Agents; Chemistry, Pharmaceutical; Dry Powder Inhalers; Fluticasone; Lactose; Particle Size; Powders; Salmeterol Xinafoate; Surface Properties

2015
Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Journal of aerosol medicine and pulmonary drug delivery, 2015, Volume: 28, Issue:4

    Topics: Aerosols; Bronchodilator Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Carriers; Drug Delivery Systems; Drug Stability; Dry Powder Inhalers; Equipment Design; Excipients; Fluticasone; Humidity; Lactose; Microscopy, Atomic Force; Powder Diffraction; Powders; Rheology; Surface Properties; Temperature; Time Factors

2015
Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers.
    The AAPS journal, 2015, Volume: 17, Issue:5

    Topics: Administration, Inhalation; Chemistry, Pharmaceutical; Dry Powder Inhalers; Equipment Design; Excipients; Fluticasone; Hydrodynamics; In Vitro Techniques; Lactose; Particle Size; Surface Properties

2015
Quantitative Macro-Raman Spectroscopy on Microparticle-Based Pharmaceutical Dosage Forms.
    Applied spectroscopy, 2015, Volume: 69, Issue:7

    Topics: Bronchodilator Agents; Fluticasone; Fluticasone-Salmeterol Drug Combination; Lactose; Particle Size; Powders; Salmeterol Xinafoate; Spectrum Analysis, Raman

2015
Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2015, Volume: 96

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adhesiveness; Administration, Inhalation; beta-Cyclodextrins; Carbohydrates; Drug Carriers; Drug Compounding; Dry Powder Inhalers; Excipients; Fluticasone; Glucose; Lactose; Mannitol; Models, Chemical; Particle Size; Porosity; Powders; Sucrose; Surface Properties; Tensile Strength; Xylitol

2015
A New Role of Fine Excipient Materials in Carrier-Based Dry Powder Inhalation Mixtures: Effect on Deagglomeration of Drug Particles During Mixing Revealed.
    AAPS PharmSciTech, 2017, Volume: 18, Issue:8

    Topics: Administration, Inhalation; Chemistry, Pharmaceutical; Drug Carriers; Dry Powder Inhalers; Excipients; Fluticasone; Lactose; Particle Size; Powders

2017
Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
    Pharmaceutical development and technology, 2018, Volume: 23, Issue:2

    Topics: Administration, Inhalation; Aerosols; Capsules; Chemistry, Pharmaceutical; Dry Powder Inhalers; Fluticasone; Lactose; Particle Size; Powders; Salmeterol Xinafoate

2018
The Relationship Between the Permeability and the Performance of Carrier-Based Dry Powder Inhalation Mixtures: New Insights and Practical Guidance.
    AAPS PharmSciTech, 2018, Volume: 19, Issue:2

    Topics: Administration, Inhalation; Aerosols; Drug Carriers; Dry Powder Inhalers; Fluticasone; Lactose; Particle Size; Permeability; Porosity; Powders

2018
Optical photothermal infrared spectroscopy for nanochemical analysis of pharmaceutical dry powder aerosols.
    International journal of pharmaceutics, 2023, Feb-05, Volume: 632

    Topics: Administration, Inhalation; Aerosols; Chemistry, Pharmaceutical; Dry Powder Inhalers; Excipients; Fluticasone; Lactose; Particle Size; Powders; Respiratory Aerosols and Droplets; Salmeterol Xinafoate; Spectrum Analysis

2023
Exploring the influence of magnesium stearate content and mixing modality on the rheological properties and in vitro aerosolization of dry powder inhaler.
    International journal of pharmaceutics, 2023, Jul-25, Volume: 642

    Topics: Administration, Inhalation; Aerosols; Drug Carriers; Dry Powder Inhalers; Fluticasone; Lactose; Particle Size; Powders

2023